Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nxera Pharma Webinar for Financial Results Presentation - 2Q2026
Tokyo, Japan and Cambridge and London, UK, 15 July 2026 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for 2Q 2026 on Friday, 7 August 2026. The Company will…
IPC signs MoU with UP Promote Pharma Council to strengthen quality standards
The Indian Pharmacopoeia Commission (IPC) has signed a memorandum of understanding (MoU) with the Uttar Pradesh Promote Pharma Council (UPPPC) to strengthen quality standards, regulatory compliance and innovation across the pharmaceutical and…
Sun Pharma gets go-ahead in South Africa to sell generic semaglutide
Drugmaker Sun Pharmaceutical Industries has received the green signal from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of…
Pharma Cos. Clash In Del. Chancery Over Dental Drug License
Ventis Pharma Inc. has sued Balanced Pharma Inc. in the Delaware Chancery Court, accusing its licensee of failing to make commercially reasonable efforts to develop and market a licensed dental anesthetic... To view the full article, register now.
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion. Index…
Calamos Advisors LLC Takes Position in Royalty Pharma PLC $RPRX
Calamos Advisors LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 437,090 shares of the biopharmaceutical company's stock, valued at…
Urogen Pharma (NASDAQ:URGN) Reaches New 52-Week High - What's Next?
Urogen Pharma (NASDAQ:URGN - Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $40.40 and last traded at $39.19, with a volume of 556070 shares traded. The stock had previously closed at…
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE and new product launches in the U.S.
Strong U.S. demand and new product launches drive first-half sales in Human Pharma Net sales reach EUR 15.8 billion, led by JARDIANCE and successful U.S. launches Positive Phase III data for survodutide and pipeline progress strengthen long-term…
Royalty Pharma PLC $RPRX Shares Sold by J. Safra Sarasin Holding AG
J. Safra Sarasin Holding AG cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 76.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned…
Principal Financial Group Inc. Has $205.03 Million Holdings in Ascendis Pharma A/S $ASND
Principal Financial Group Inc. trimmed its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 12.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 896,397 shares of the biotechnology company's…
Why Semaglutide is an inflection point for India's generics sector?
More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for India's pharmaceutical industry, which supplies about 20% of the world's generic medicines by…
45,611 Orion Corporation A shares converted into B shares
STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 45,611 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 45,611 A…
/afaqs/media/media_files/2026/07/15/revital-2026-07-15-15-45-40.jpg)
Revital highlights the impact of stress in new ad with Vicky Kaushal
Revital, the multivitamin brand from Sun Pharmaceutical Industries, has launched an integrated campaign featuring actor Vicky Kaushal. The campaign focuses on how stress and the demands of modern lifestyles may contribute to everyday fatigue beyond…
Life sciences leaders face urgent workforce redesign challenge as AI reshapes productivity, skills and operating models
As artificial intelligence continues to transform drug discovery, clinical development, manufacturing, commercial operations and enabling functions across life sciences, senior HR and workforce transformation leaders are facing a new strategic…
In the Weight-Loss Wars, Novo's Obesity Pill Is Pulling Way Ahead of Lilly's
The launch of weight-loss pills is the hottest battle in pharma. So far, is losing to rival. Since its obesity pill Foundayo hit the market in April, Lilly has captured about 11% of the prescription volume for new pills, according to the latest…
Receive a Daily briefing on Pharma Industry News
Get Started